Molecular epidemiology of carbapenem-resistant gram-negative bacilli in Ecuador

被引:0
|
作者
Soria-Segarra, Claudia [1 ,2 ,3 ,4 ]
Soria-Segarra, Carmen [1 ,5 ]
Molina-Matute, Marcos [6 ]
Agreda-Orellana, Ivanna [6 ]
Nunez-Quezada, Tamara [7 ]
Cevallos-Apolo, Kerly [8 ]
Miranda-Ayala, Marcela [9 ]
Salazar-Tamayo, Grace [10 ]
Galarza-Herrera, Margarita [11 ]
Vega-Hall, Victor [12 ]
Villacis, Jose E. [13 ]
Gutierrez-Fernandez, Jose [3 ,4 ,14 ]
机构
[1] Med Serv, Sosecali, Guayaquil 090308, EC, Ecuador
[2] Guayaquil Univ, Fac Med Sci, Guayaquil, Ecuador
[3] Univ Granada & ibs, Sch Med, Dept Microbiol, Granada, Spain
[4] Univ Granada & ibs, PhD Program Clin Med & Publ Hlth, Granada, Spain
[5] Univ Catolica Santiago Guayaquil, Sch Med, Dept Internal Med, Guayaquil, Ecuador
[6] Hosp Rio, Cuenca, Ecuador
[7] Hosp Inst Ecuatoriano Seguridad Social Dr Teodoro, Guayaquil, Ecuador
[8] Hosp Infectol Dr Jose Daniel Rodriguez Mariduena, Guayaquil, Ecuador
[9] Omni Hosp, Guayaquil, Ecuador
[10] Hosp Vozandez, Quito, Ecuador
[11] Hosp Eugenio Espejo, Quito, Ecuador
[12] Interhosp, Guayaquil, Ecuador
[13] Pontificia Univ Catolica Ecuador, Ctr Invest Salud Amer Latina CISeAL, Quito 17012184, Ecuador
[14] Hosp Virgen Nieves, Inst Biosanit Res Ibs, Dept Microbiol, Granada, Spain
关键词
Carbapenem resistance; Carbapenemase genes; Ecuador; Gram-negative bacilli; COLISTIN RESISTANCE; MULTIPLEX PCR; AMERICA;
D O I
10.1186/s12879-024-09248-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction Carbapenem-resistant gram-negative bacilli are a worldwide concern because of high morbidity and mortality rates. Additionally, the increasing prevalence of these bacteria is dangerous. To investigate the extent of antimicrobial resistance and prioritize the utility of novel drugs, we evaluated the molecular characteristics and antimicrobial susceptibility profiles of carbapenem-resistant Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii in Ecuador in 2022.Methods Ninety-five clinical isolates of carbapenem non-susceptible gram-negative bacilli were collected from six hospitals in Ecuador. Carbapenem resistance was confirmed with meropenem disk diffusion assays following Clinical Laboratory Standard Institute guidelines. Carbapenemase production was tested using a modified carbapenemase inactivation method. Antimicrobial susceptibility was tested with a disk diffusion assay, the Vitek 2 System, and gradient diffusion strips. Broth microdilution assays were used to assess colistin susceptibility. All the isolates were screened for the bla KPC, bla NDM, bla OXA-48, bla VIM and bla IMP genes. In addition, A. baumannii isolates were screened for the bla OXA-23, bla OXA-58 and bla OXA-24/40 genes.Results Carbapenemase production was observed in 96.84% of the isolates. The bla KPC, bla NDM and bla OXA-48 genes were detected in Enterobacterales, with bla KPC being predominant. The bla VIM gene was detected in P. aeruginosa, and bla OXA-24/40 predominated in A. baumannii. Most of the isolates showed co-resistance to aminoglycosides, fluoroquinolones, and trimethoprim/sulfamethoxazole. Both ceftazidime/avibactam and meropenem/vaborbactam were active against carbapenem-resistant gram-negative bacilli that produce serin-carbapenemases.Conclusion The epidemiology of carbapenem resistance in Ecuador is dominated by carbapenemase-producing K. pneumoniae harbouring bla KPC. Extensively drug resistant (XDR) P. aeruginosa and A. baumannii were identified, and their identification revealed the urgent need to implement strategies to reduce the dissemination of these strains.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
    George G. Zhanel
    Alyssa R. Golden
    Sheryl Zelenitsky
    Karyn Wiebe
    Courtney K. Lawrence
    Heather J. Adam
    Temilolu Idowu
    Ronald Domalaon
    Frank Schweizer
    Michael A. Zhanel
    Philippe R. S. Lagacé-Wiens
    Andrew J. Walkty
    Ayman Noreddin
    Joseph P. Lynch III
    James A. Karlowsky
    Drugs, 2019, 79 : 271 - 289
  • [22] Predictors of Mortality in Patients with Carbapenem-Resistant Gram-Negative Bacilli or Vancomycin-Resistant Enterococci Bacteremia
    Shi, Hye Jin
    Lee, Jin Seo
    Cho, Yong Kyun
    Eom, Joong Sik
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 3535 - 3542
  • [23] Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
    Zhanel, George G.
    Golden, Alyssa R.
    Zelenitsky, Sheryl
    Wiebe, Karyn
    Lawrence, Courtney K.
    Adam, Heather J.
    Idowu, Temilolu
    Domalaon, Ronald
    Schweizer, Frank
    Zhanel, Michael A.
    Lagace-Wiens, Philippe R. S.
    Walkty, Andrew J.
    Noreddin, Ayman
    Lynch, Joseph P., III
    Karlowsky, James A.
    DRUGS, 2019, 79 (03) : 271 - 289
  • [24] Treatment Options for Carbapenem-Resistant Gram-Negative Infections
    Fritzenwanker, Moritz
    Imirzalioglu, Can
    Herold, Susanne
    Wagenlehner, Florian M.
    Zimmer, Klaus-Peter
    Chakraborty, Trinad
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2018, 115 (20-21): : 345 - +
  • [25] Treatment Options for Carbapenem-Resistant Gram-Negative Infections
    Bodmann, Klaus-Friedrich
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2019, 116 (07): : 115 - 115
  • [26] Combination therapy for carbapenem-resistant Gram-negative bacteria
    Paul, Mical
    Carmeli, Yehuda
    Durante-Mangoni, Emanuele
    Mouton, Johan W.
    Tacconelli, Evelina
    Theuretzbacher, Ursula
    Mussini, Cristina
    Leibovici, Leonard
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (09) : 2305 - 2309
  • [27] Combination therapy for carbapenem-resistant Gram-negative bacteria
    Zavascki, Alexandre P.
    Bulitta, Jurgen B.
    Landersdorfer, Cornelia B.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2013, 11 (12) : 1333 - 1353
  • [28] Worldwide proliferation of carbapenem-resistant gram-negative bacteria
    Kurokawa, H
    Yagi, T
    Shibata, N
    Shibayama, K
    Arakawa, Y
    LANCET, 1999, 354 (9182): : 955 - 955
  • [29] Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
    Jean, Shio-Shin
    Harnod, Dorji
    Hsueh, Po-Ren
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [30] The global threat of carbapenem-resistant gram-negative bacteria
    Dropa, Milena
    Daoud, Ziad
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12